Lataa...
The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a negative regulator of T-cell mediated immune responses and is the target of new anti-tumor immunotherapy strategies. Ipilimumab is a fully human, antagonistic monoclonal antibody directed against CTLA-4. Results from preclinical and early clinical trial...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Academy of Cancer
Immunology
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2935787/ https://ncbi.nlm.nih.gov/pubmed/18198818 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|